New EU Filings Include Incyte’s Povorcitinib & Sanofi’s SP0087, US Next In Line

 
• By Neena Brizmohun
  
Hidradenitis Suppurativa Word On Cubes
Incyte has filed an EU marketing application for its oral drug for hidradenitis suppurativa (Shutterstock)

More from EU CHMP

More from Pink Sheet